Lutetium-177-DOTAGA-IAC

Developed for: breast cancer
Investigated by: Advanced Imaging Projects, LLC · Postgraduate Institute of Medical and Research · University of Witwatersrand, South Africa

today NCT04469127 · Ph 1/2

20252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT04469127	Sep 2024 → Aug 2025	breast cancer	Advanced Imaging Projects, LLC	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Lutetium-177-DOTAGA-IAC	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04469127 ↗
Route	Other	“Single Arm study Lu-177-DOTAGA-IAC (intracutaneous)” NCT04469127 ↗